Wolverine Trading, LLC Roivant Sciences Ltd. Transaction History
Wolverine Trading, LLC
- $96.9 Billion
- Q2 2025
A detailed history of Wolverine Trading, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Wolverine Trading, LLC holds 20,725 shares of ROIV stock, worth $352,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,725
Previous 14,103
46.95%
Holding current value
$352,117
Previous $142,000
64.08%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.02 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$759 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$668 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$601 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$582 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $12B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...